Better Therapeutics, Inc.

The momentum for this stock is not very good. Better Therapeutics, Inc. is not a good value stock. Better Therapeutics, Inc. is not a good growth stock. Tradey thinks it is not wise to invest in Better Therapeutics, Inc..
Log in to see more information.

News

Analyzing Better Therapeutics (NASDAQ:BTTX) and Agape ATP (NASDAQ:ATPC)
Analyzing Better Therapeutics (NASDAQ:BTTX) and Agape ATP (NASDAQ:ATPC)

Zolmax Agape ATP (NASDAQ:ATPC Get Free Report) and Better Therapeutics (NASDAQ:BTTX Get Free Report) are both small-cap medical companies, but which is the better business? We will compare...\n more…

12 titoli sanitari in movimento, pre-market del 15/03/2024
12 titoli sanitari in movimento, pre-market del 15/03/2024

Benzinga Titoli in rialzo Le azioni di Better Therapeutics (NASDAQ:BTTX) hanno guadagnato il 69,14% a 0,06 dollari durante la sessione pre-market di venerdì. Le azioni di Madrigal Pharmaceuticals (NASDAQ:MDGL) hanno guadagnato\n more…

12 acciones de salud en movimiento durante la preapertura del 15/03/2024
12 acciones de salud en movimiento durante la preapertura del 15/03/2024

Benzinga Acciones al alza Better Therapeutics (NASDAQ:BTTX) ganaron un 77,14% para establecerse en los 0,06 dólares durante la sesión del pre-market del viernes. Madrigal Pharmaceuticals (NASDAQ:MDGL) avanzaron un 22,96% para\n more…

Better Therapeutics trading resumes
Better Therapeutics trading resumes

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Better Therapeutics to seek strategic alternatives, be delisted from Nasdaq
Better Therapeutics to seek strategic alternatives, be delisted from Nasdaq

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Better Therapeutics Announces it will Seek Strategic Alternatives and will be Delisted from Nasdaq
Better Therapeutics Announces it will Seek Strategic Alternatives and will be Delisted from Nasdaq

Business Wire Better Therapeutics, Inc. (NASDAQ: BTTX) (the Company) announced today that the Company is terminating its employees and will explore strategic alternatives, including assignment for the benefit of...\n more…